Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

5(83.3%)

Phase 3

1(16.7%)

6Total

Phase 1(5)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07457229Phase 1Recruiting

Radiprodil in Participants With Hepatic Impairment

Role: lead

NCT06392009Phase 1Active Not Recruiting

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

Role: lead

NCT07224581Phase 3Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

Role: lead

NCT06965881Phase 1Terminated

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

Role: lead

NCT06975605Phase 1Completed

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

Role: lead

NCT05818943Phase 1Active Not Recruiting

Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder

Role: lead

All 6 trials loaded